Precision epigenomics,
driving Life Sciences forward.
We support researchers at every stage of discovery.
With over 20 years of epigenomic expertise, Hologic Diagenode helps scientists gain deeper insights with greater confidence.
We are passionate about accelerating breakthroughs.
By integrating epigenomics and bioinformatics, we drive early detection, patient screening, and MRD monitoring—shortening timelines before clinical trials.
Acquired by Hologic in March 2021, Hologic Diagenode is a global leader in epigenomics. We deliver comprehensive solutions across DNA methylation, chromatin, transcriptomics, and genomics, streamlining research, supporting pharmaceutical companies, and enabling new insights for scientific and medical communities.
How to Find Us
